NasdaqGS - Delayed Quote USD
ImmunityBio, Inc. (IBRX)
At close: November 7 at 4:00 PM EST
After hours: 7:55 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ADCOCK RICHARD Chief Executive Officer | Conversion of Exercise of derivative security | Feb 5, 2024 | 243,138 |
| BLASZYK MICHAEL D Director | Purchase | Jun 5, 2023 | -- |
| BRENNAN JOHN OWEN Director | Purchase | Jun 2, 2023 | 25,000 |
| CLARK WESLEY K Director | Purchase | Jun 1, 2023 | 8,000 |
| LAUER REGAN J Officer | Conversion of Exercise of derivative security | Jan 31, 2024 | 94,334 |
| SACHS DAVID C Chief Financial Officer | Conversion of Exercise of derivative security | Jan 31, 2024 | 185,838 |
| SIMON BARRY J. M.D. Director | Conversion of Exercise of derivative security | Jan 31, 2024 | 3,123,760 |
| SOON SHIONG PATRICK Officer, Director and Beneficial Owner | Conversion of Exercise of derivative security | Dec 12, 2022 | -- |
Related Tickers
IOVA Iovance Biotherapeutics, Inc.
12.28
+1.15%
SMMT Summit Therapeutics Inc.
21.10
+1.01%
TGTX TG Therapeutics, Inc.
27.90
+2.69%
MDGL Madrigal Pharmaceuticals, Inc.
354.85
+4.92%
ALT Altimmune, Inc.
7.46
+2.05%
ADMA ADMA Biologics, Inc.
19.72
+0.25%
ENSC Ensysce Biosciences, Inc.
0.6957
+26.42%
LXRX Lexicon Pharmaceuticals, Inc.
1.3000
+7.44%
AVXL Anavex Life Sciences Corp.
7.64
-1.99%
SGMO Sangamo Therapeutics, Inc.
2.8100
+13.77%